Bilateral optic neuritis as a first presentation of lymph node tuberculosis.Keshavan A, McAnena L, Acheson JF, Booth H, Plant GT,?Khaleeli Z.Pract Neurol. 2022 Feb;22(1):51-54. Epub 2021 Jul 28.
Remember the Retina: Retinal disorders presenting to Neurologists. Z Khaleeli, L del Porto, W R Tucker, A Webster, G T Plant. Pract Neurol. 2018 Apr;18(2):84-96.
A novel HTRA1exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient. Zhaleh Khaleeli, Zane Jaunmuktane, Nathalie Beaufort, Henry Houlden, Christof Haffner, Sebastian Brandner, Martin Dichgans, and David Werring. J Neurol. 2015 May;262(5):1369-72
Copper deficiency as a treatable cause of poor balance. Khaleeli Z, Healy DG, Briddon A, Lunn MP, Reilly MM, Land J, Giovannoni G.BMJ. 2010 Apr 12;340:c508.
Lesion enhancement diminishes with time in primary progressive multiple sclerosis. Khaleeli Z, Ciccarelli O, Mizskiel K, Altmann D, Miller DH, Thompson AJ.Mult Scler. 2010 Mar;16(3):317-24
Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. Khaleeli Z, Altmann DR, Cercignani M, Ciccarelli O, Miller DH, Thompson AJ.Arch Neurol. 2008 Nov;65(11):1454-9.
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study. Khaleeli Z, Ciccarelli O, Manfredonia F, Barkhof F, Brochet B, Cercignani M, Dousset V, Filippi M, Montalban X, Polman C, Rovaris M, Rovira A, Sastre-Garriga J, Vellinga M, Miller D, Thompson A.Ann Neurol. 2008 Jun;63(6):790
Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Khaleeli Z, Cercignani M, Audoin B, Ciccarelli O, Miller DH, Thompson AJ.Neuroimage. 2007 Aug 1;37(1):253-61. Epub 2007 May 18
Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis.Manfredonia F, Ciccarelli O, Khaleeli Z, Tozer DJ, Sastre-Garriga J, Miller DH, Thompson AJ.Arch Neurol. 2007 Mar;64(3):411-5
Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.Khaleeli Z, Sastre-Garriga J, Ciccarelli O, Miller DH, Thompson AJ.J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1076-82. Epub 2007 Feb 714
Harmony or hegemony? The rise and fall of the native medical institution, Calcutta, 1822-35. Khaleeli Z.South Asia Res. 2001;21(1):77-104.
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. Kimberley Allen-Philbey , Stefania De Trane, Zhifeng Mao, Cesar Álvarez-González, Joela Mathews, Amy MacDougall, Andrea Stennett, Xia Zhou, Ozlem Yildiz, Ashok Adams,Lucia Bianchi, Camilla Blain, Christine Chapman, Karen Chung, Cris S Constantinescu,Catherine Dalton, Rachel A Farrell, Leonora Fisniku, Helen Ford, Bruno Gran,Jeremy Hobart, Zhaleh Khaleeli, Miriam Mattoscio, Sue Pavitt, Owen Pearson,Luca Peruzzotti-Jametti, Antonio Scalfari, Basil Sharrack, Eli Silber, Emma C Tallantyre,Stewart Webb, Benjamin P Turner, Monica Marta, Sharmilee Gnanapavan, Gunnar, Juliusson, Gavin Giovannoni , David Baker and Klaus Schmierer
Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up. Petzold A, Woodhall M, Khaleeli Z, Tobin WO, Pittock SJ, Weinshenker BG, Vincent A, Waters P, Plant GT. J Neurol Neurosurg Psychiatry. 2019 May 22.
Clinical relevance of cortical network dynamics in early primary progressive MS. Tur C, Kanber B, Eshaghi A, Altmann DR, Khaleeli Z, Prados F, Ourselin S, Thompson AJ, Gandini Wheeler-Kingshott CA, Toosy AT, Ciccarelli O.Mult Scler. 2019 Feb
HLA-DRB1*15 influences the development of brain tissue damage in early PPMS.Tur C, Ramagopalan S, Altmann DR, Bodini B, Cercignani M, Khaleeli Z, Miller DH, Thompson AJ, Ciccarelli O.Neurology. 2014 Nov 4;83(19):1712-8.
Corpus callosum damage predicts disability progression and cognitive dysfunction in primary-progressive MS after five years. Bodini B, Cercignani M, Khaleeli Z, Miller DH, Ron M, Penny S, Thompson AJ, Ciccarelli O. Hum Brain Mapp. 2012 Feb 13
Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.Tur C, Penny S, Khaleeli Z, Altmann DR, Cipolotti L, Ron M, Thompson AJ, Ciccarelli O.Mult Scler. 2011 Nov;17(11):1324-32. Epub 2011 Jul 29.
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS.Tur C, Khaleeli Z, Ciccarelli O, Altmann DR, Cercignani M, Miller DH, Thompson AJ. J Neurol Neurosurg Psychiatry. 2010 Oct 25
Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study.Anderson VM, Fisniku LK, Khaleeli Z, Summers MM, Penny SA, Altmann DR, Thompson AJ, Ron MA, Miller DH.Mult Scler. 2010 Sep;16(9):1083-90.
T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.Bodini B, Battaglini M, De Stefano N, Khaleeli Z, Barkhof F, Chard D, Filippi M, Montalban X, Polman C, Rovaris M, Rovira A, Samson R, Miller D, Thompson A, Ciccarelli O.J Neurol Neurosurg Psychiatry. 2011Jan;82(1):72-7.
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?Bosma LV, Kragt JJ, Brieva L, Khaleeli Z, Montalban X, Polman CH, Thompson AJ, Tintoré M, Uitdehaag BM. Mult Scler. 2010 Jul;16(7):862-7. Epub 2010 May 20.
Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. Penny S, Khaleeli Z, Cipolotti L, Thompson A, Ron M.Neurology. 2010 Feb 16;74(7):545-52.
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ. Mult Scler. 2009 Dec;15(12):1459-65.
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G.Neurology. 2009 Jul 7;73(1):32-8.
The search for responsive clinical endpoints in primary progressive multiple sclerosis.Bosma LV, Kragt JJ, Brieva L, Khaleeli Z, Montalban X, Polman CH, Thompson AJ, Tintoré M, Uitdehaag BM.Mult Scler. 2009 Jun;15(6):715-20.
Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM.Bodini B, Khaleeli Z, Cercignani M, Miller DH, Thompson AJ, Ciccarelli O.Hum Brain Mapp. 2009 Sep;30(9):2852-61
Diagnosis and management of primary progressive multiple sclerosis. Jenkins TM, Khaleeli Z, Thompson AJ.Minerva Med. 2008 Apr;99(2):141-55
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis.Rovaris M, Judica E, Sastre-Garriga J, Rovira A, Sormani MP, Benedetti B, Korteweg T, De Stefano N, Khaleeli Z, Montalban X, Barkhof F, Miller DH, Polman C, Thompson AJ, Filippi M.Mult Scler. 2008 May;14(4):455-64. Epub 2008 Jan 21
